Fact: Basal Bolus Outperforms Premix Analog Insulin

Basal Bolus Outperforms Premix Analog Insulin: Patients using Lantus(R) once-daily and Apidra(R) before meals reported improved patient reported outcomes and decreased glycemic variability versus premix analog insulin. People following a basal-bolus insulin regimen use separate injections of a basal insulin and a mealtime insulin. This regimen is designed to address hyperglycemia before it happens by providing adequate insulin to cover fasting and prandial insulin needs. A premix insulin regimen combines prandial insulin analogs and the intermediate-acting insulin, NPH, in one injection. The results of this study demonstrated that patients using a basal-bolus regimen, with Lantus and Apidra, reported improved outcomes and quality of life. Study Findings Presented at American Diabetes Association's 70th Annual Scientific Sessions